Bart De Strooper co-founded Augustine Therapeutics alongside Ludo Van Den Bosch and Joris De Wit, researchers with strong academic credentials in neuroscience. The company raised EUR 77.7M in a Series A round in H1 2025, one of the larger biotech rounds in recent Belgian history, with participation from PMV and other investors.
From public career histories · 1 entry